CVRx | Barostim
Avatar

The Need for Device Therapy in HFrEF

By CVRx | Barostim FEATURING William Abraham
By CVRx | Barostim FEATURING William Abraham
267 views
March 23, 2022
Dr. Abraham describes the need for device therapy in HFrEF
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
10:21
CVRx | Barostim

Patient Identification and Post-Implant Management within an Advance…

Feat. D. Yaranov
17:33
CVRx | Barostim

Beyond BeAT-HF: Real World Experience with Barostim

Feat. G. Panjrath
15:57
CVRx | Barostim

Long-Term Results of the BeAT-HF Clinical Study

Feat. J. Lindenfeld
13:58
CVRx | Barostim

Challenges and Opportunities with Contemporary GDMT (Dr. Heywood)

Feat. J. Thomas Heywood
11:18
CVRx | Barostim

Barostim and the Window of Opportunity in Class II/III HFrEF Patient…

Feat. G. Panjrath, D. Yaranov, J. Lindenfeld, J. Thomas Heywood
18:36
CVRx | Barostim

Barostim and the Window of Opportunity in Class II/III HFrEF Patient…

Feat. W. Abraham, G. Panjrath, D. Yaranov, P. Mccann
09:58
CVRx | Barostim

Barostim for HFrEF Patients

Feat. P. Mccann
10:18
CVRx | Barostim

New Insights from the BeAT-HF Clinical Study

Feat. W. Abraham
06:16
CVRx | Barostim

Challenges and Opportunities with Contemporary GDMT

Feat. D. Yaranov
12:16
CVRx | Barostim

HFSA 2023: Window of Opportunity – Who and When

Feat. G. Panjrath
16:32
CVRx | Barostim

ESC 2023: BeAT-HF: Long term outcome

Feat. M. Zile
11:49
CVRx | Barostim

ESC 2023: Unmet needs and opportunities with device therapies of HFr…

Feat. W. Abraham
11:43
CVRx | Barostim

ESC 2023: Real-world experience with Baroreflex Activation Therapy

Feat. F. Arribas
06:23
CVRx | Barostim

ESC 2023: Baroreflex Activation Therapy for HFrEF Patients: Long-Ter…

Feat. W. Abraham, F. Arribas, M. Zile
16:00
CVRx | Barostim

HFA 2023: BeAT-HF: Long-Term Safety Profile and Outcomes

Feat. F. Zannad
12:14
CVRx | Barostim

HFA 2023: Challenges and Unmet Needs in GDMT for HFrEF

Feat. J. Lindenfeld
07:42
CVRx | Barostim

HFA 2023: Autonomic Dysfunction in HFrEF

Feat. M. Fudim
18:26
CVRx | Barostim

HFA 2023: Unlocking the Potential of Baroreflex Activation in Heart …

Feat. F. Zannad, J. Lindenfeld, M. Fudim
10:51
CVRx | Barostim

VAM 2023: Baroreflex Activation Therapy - A Novel Extravascular Proc…

Feat. M. PEREZ-IZQUIERDO
13:58
CVRx | Barostim

Challenges and Opportunities with Contemporary GDMT (Dr. Heywood)

Feat. J. Thomas Heywood
11:37
ACC 2022 Conference Coverage

ACC 2022: An Embarrassment of Riches - Updated Guideline Recommendat…

Feat. P. Heidenreich
18:00
ACC 2023 Conference Coverage

ACC 2023: Catch Them Before They Fall - Syncope Guidelines in Action

Feat. B. Olshansky
52:47
Miami Valves 2022

Physiologic Pacing, Patient Selection, Techniques and Outcomes

Feat. K. ELLENBOGEN
16:31
Courage and Innovation Symposium: Heart Failure & Heart Transplantation

Cardiac Sarcoidosis: Improving Diagnosis and Management

Feat. B. Chung
10:20
4th Annual Physiology of Pacing Symposium

New Technologies for LV Endocardial Pacing and Cardiac Contractility…

Feat. J. Singh
04:22
CVRx | Barostim

Barostim Patient Identification

Feat. R. Canby
36:07
Scripps Health

Disparities in Care: Pacer/ICD/CRT in WOMEN - a 2023 Update

Feat. J. Rogers
09:39
CVRx | Barostim

Unmet Needs and Device Therapies in HFrEF

Feat. J. Singh
07:41
CVRx | Barostim

New Options for Heart Failure Patients with Narrow QRS

Feat. J. Singh
18:06
Ulrika Birgersdotter-Green

Antitachycardia Pacing and VT Termination: Fact or Fancy?

09:16
6th Annual Physiology of Pacing Symposium

Optimizing CRT in 2022: Program, Monitor and Escalate!

Feat. G. Upadhyay
18:30
ACC 2023 Conference Coverage

ACC 2023: Managing ICDs and CRTs in Patients With LVADs

Feat. R. Gopinathannair
19:17
CVRx | Barostim

EP Lab Digest Panel Q&A

Feat. J. Lindenfeld, R. Canby, N. Raval, B. Knight
08:28
10th Annual California Heart Rhythm Symposium

Debate: Should VT Ablation Be the First Line Therapy Before ICD Impl…

Feat. W. Sauer
06:09
CVRx | Barostim

The Need for New Device Therapies in HFrEF

Feat. J. Singh
14:24
Taya Glotzer

CRT Is the Preferred Form of Conduction System Pacing in Heart Failu…

11:50
AHA 2022 Conference Coverage

AHA 2022: Risk Stratification and Treatment of Ventricular Arrhythmi…

Feat. E. Kaufman
15:40
CVRx | Barostim

Clinical Data and Patient Experience with Barostim

Feat. N. Raval
09:00
Scripps Health

Management of 46 y/o Man with Non-ischemic Cardiomyopathy with LVEF …

Feat. J. Rogers